胸腔镜肺癌根治术后肺部感染病原菌及miR-1323/IL-6、IL-23/IL-17表达

Pathogenic bacteria and expression of miR-1323/IL-6 and IL-23/IL-17 in pulmonary infection after thoracoscopic radical cancer surgery

  • 摘要:
    目的 探讨胸腔镜肺癌根治术后肺部感染病原菌及微小RNA-1323/白细胞介素-6(miR-1323/IL-6)、IL-23/IL-17表达。
    方法 选择2019年1月-2023年11月徐州医科大学附属医院实施胸腔镜肺癌根治术治疗且术后发生肺部感染的110例肺癌患者作为感染组, 根据术后6个月后的预后情况分组, 另选取同期实施胸腔镜肺癌根治术治疗且术后未发生肺部感染的110例肺癌患者作为未感染组。采集胸腔镜肺癌根治术后肺部感染患者痰液进行病原学检测, 统计其病原菌构成。对比感染组与未感染组、胸腔镜肺癌根治术后肺部感染患者不同预后分组miR-1323/IL-6、IL-23/IL-17表达, 绘制受试者工作特征(ROC)曲线分析miR-1323/IL-6、IL-23/IL-17评估胸腔镜肺癌根治术后肺部感染患者短期预后的预测效能。
    结果 感染组外周血miR-1323相对表达量、血清IL-6、IL-23、IL-17水平高于未感染组(P<0.05); 110例胸腔镜肺癌根治术后肺部感染患者痰液中检出125株病原菌, 革兰阴性菌占73.60%(92/125), 革兰阳性菌占20.80%(26/125), 真菌占比5.60%(7/125); 110例胸腔镜肺癌根治术后肺部感染患者预后不良32例, 预后良好78例, 预后不良组外周血miR-1323相对表达量、血清IL-6、IL-23、IL-17水平高于预后良好组(P<0.05); ROC曲线分析结果显示, 外周血miR-1323、血清IL-6、IL-23、IL-17联合检测对胸腔镜肺癌根治术后肺部感染患者预后的曲下线面积(AUC)为0.944, 敏感度和特异度分别为90.60%、87.20%, 均高于各指标单独检测(P<0.05)。
    结论 胸腔镜肺癌根治术后肺部感染的病原菌以革兰阴性菌居多, 外周血miR-1323、血清IL-6、IL-23、IL-17在胸腔镜肺癌根治术后肺部感染患者中高表达, 各指标联合检测对患者预后具有更高预测效能。

     

    Abstract:
    OBJECTIVE To investigate the pathogenic bacteria of pulmonary infection and the expression of microRNA-1323 (miR-1323)/interleukin (IL)-6 and IL-23/ IL-17 after thoracoscopic radical lung cancer surgery.
    METHODS A total of 110 lung cancer patients who underwent thoracoscopic radical resection and developed postoperative lung infection in the Affiliated Hospital of Xuzhou Medical University from Jan. 2019 to Nov. 2023 were selected as the infection group and further sub-grouped according to the prognosis after the surgery for 6 months. Another 110 patients without pulmonary infection after surgery were selected as the uninfected group. Sputum from the infection group were collected for etiological detection, and the composition of pathogenic bacteria was analyzed. The expression of miR-1323/IL-6 and IL-23/IL-17 were compared between the infected and uninfected group and among different prognostic subgroups. Receiver operating characteristic (ROC) curve analyzed the efficacy of miR-1323/IL-6 and IL-23/IL-17 in evaluating the short-term prognosis of patients with pulmonary infection after thoracoscopic radical lung cancer surgery.
    RESULTS The relative level of miR-1323 in peripheral blood and serum levels of IL-6, IL-23 and IL-17 in the infected group were higher than those in uninfected group(P < 0.05). Totally 125 strains of pathogenic bacteria were detected in the sputum of 110 patients with pulmonary infection after surgery, of which gram-negative bacteria accounted for 73.60% (92/125), gram-positive bacteria 20.80% (26/125) and fungi 5.60% (7/125). Among the 110 patients with pulmonary infection after surgery, thirty-two had poor prognosis and 78 had good prognosis. The relative level of miR-1323 in peripheral blood and serum levels of IL-6, IL-23 and IL-17 in the poor prognosis group were higher than those in the good prognosis group, respectively (P < 0.05). The combined detection of miR-1323, IL-6, IL-23 and IL-17 on the prognosis of pulmonary infection after surgery had an area under the curve (AUC) of 0.944 with the sensitivity and specificity of 90.60% and 87.20%, respectively, which was higher than that of each index alone (P < 0.05).
    CONCLUSION For lung infection after thoracoscopic radical lung cancer surgery, the pathogens are mostly gram-negative bacteria, and peripheral blood miR-1323 and serum IL-6, IL-23 and IL-17 express highly, and their combined detection has high predictive function on the prognosis.

     

/

返回文章
返回